Patients with type 1 diabetes missing out on glucose devices

November 7, 2018, British Medical Journal

Tens of thousands of UK patients with type 1 diabetes are being denied the potential benefits of flash glucose monitoring devices because of a postcode lottery, an investigation by The BMJ has found.

Abbott's Freestyle Libre is currently the only available in the UK.

But the investigation shows that a year after the device became available, around a quarter of clinical commissioning groups (CCGs) in England are not recommending it for even if they meet NHS England criteria.

There are roughly 400,000 people in the UK with type 1 , including the UK prime minister Theresa May, who uses Freestyle Libre and recently told parliament that it is available on the NHS.

But Partha Kar, NHS England's associate national clinical director for diabetes, estimates that only around 3-5% of patients with type 1 diabetes in England currently have access to the sensor on the NHS. If CCGs were following guidance correctly, he believes this figure should be closer to 20-25% - if not higher.

He said some CCGs were merely paying "lip service" to offering access to the devices, and that variation in how the criteria were being applied had led to an unacceptable postcode lottery.

Consultant diabetologist Emma Wilmot, who treats patients who can access the device and others who can't, says some patients are considering moving to a different GP practice a few miles down the road to meet the criteria, while others were making "huge sacrifices" to fund Libre themselves.

Data disclosed by CCGs to The BMJ in response to Freedom of Information requests show that some CCGs have made the devices available to hundreds of patients via GPs and have spent thousands on prescriptions, while some say that the devices are only prescribed by secondary care clinicians.

And some CCGs are imposing stricter access criteria than those recommended by NHS England leading GPs to ignore this advice because they believe the device will help their patients.

Meanwhile, official prescribing data collated by the diabetes campaigner Nick Cahm and shared with The BMJ suggests that only 2% of patients with type 1 diabetes in England are getting Libre on GP prescription, compared to 11% in Scotland, 16% in Wales, and 35% in Northern Ireland.

As of July 2018, GP prescribing data showed that only only two out of 195 CCGs in England had prescribed Freestyle Libre to more than 20% of patients with type 1 diabetes, only 15 CCGs had prescribed it to over 10% of type 1 patients, and 25 CCGs had issued no prescriptions at all.

Cahm told The BMJ: "Lots of the variation doesn't need to be there. Being a type 1 diabetic is the same whether you're in Birmingham, London, or Northern Ireland. It doesn't seem to be logical. Decisions should be made by a specialist advisory panel."

The BMJ has also learnt that some GPs in areas where CCGs have not recommended flash monitoring are prescribing Freestyle Libre against their CCG's advice.

Nick Cahm said that some CCGs were only thinking about their short term finances rather than long term gains that could occur if patients type 1 diabetes have better control of their condition, and suffer fewer complications in years to come.

Emma Wilmot believes that Freestyle Libre is one of the biggest "life changing" advancements in type 1 diabetes care for many years, and that "by preventing people having access to the Libre you are compromising their quality of life compared to what it could be."

Julie Wood, chief executive of NHS Clinical Commissioners, said: "Unfortunately the NHS does not have unlimited resources and ensuring patients get the best possible care against a backdrop of spiralling demands, competing priorities and increasing financial pressures is one of the biggest issues CCGs face."

Explore further: Sharp rise in requests for knee and hip surgery being turned down

More information: The BMJ, DOI: 10.1136/bmj.k4675 ,

Related Stories

Sharp rise in requests for knee and hip surgery being turned down

July 18, 2018
Nearly 1,700 requests rejected last year, a 45% increase from 2016-17, reveals an investigation by The BMJ.

Diabetes monitor is 'game changer'

February 22, 2018
A new method of measuring blood glucose levels in people with diabetes is a significant advance in the management of the disease, according to an independent assessment by University of Manchester, Manchester University NHS ...

Concerns over inconsistent palliative care provision across England

February 28, 2017
Palliative and end-of-life care are not being considered as core services by clinical commissioning groups (CCGs) in some parts of England, with a vast degree of variation across different services and regions, reveals an ...

Bans on gluten-free prescribing save the NHS money in the short-term but the impact on patients is unclear

August 2, 2018
Full or partial bans on GPs prescribing gluten-free (GF) foods to people with coeliac disease save the NHS money in the short-term. But the impact on patients, especially those from deprived areas, is unknown, NIHR-funded ...

The BMJ reveals private firms run one-third of CCGs' schemes to screen GP referrals

January 4, 2017
Clinical commissioning groups (CCGs) in England are spending millions of pounds on schemes that screen patient referrals from GPs to specialist services, reveals an investigation by The BMJ today.

BMJ investigation finds GPs being forced to ration access to hospital care

July 10, 2013
Clinical commissioning groups in England have begun implementing new restrictions on referrals to secondary care as they strive to manage their resources amid increasing financial restraints, reveals a BMJ investigation today.

Recommended for you

Can't exercise? A hot bath may help improve inflammation, metabolism, study suggests

November 14, 2018
Hot water treatment may help improve inflammation and blood sugar (glucose) levels in people who are unable to exercise, according to a new study. The findings are published ahead of print in the Journal of Applied Physiology.

Diabetic foot ulcers heal quickly with nitric oxide technology

November 12, 2018
Diabetic foot ulcers can take up to 150 days to heal. A biomedical engineering team wants to reduce it to 21 days.

Diabetes drug might also ease heart failure risks

November 12, 2018
(HealthDay)—The diabetes drug Farxiga might do double-duty for patients, helping to ward off another killer, heart failure, new research shows.

Marijuana use tied to serious diabetes complication

November 8, 2018
(HealthDay)—People with type 1 diabetes who use marijuana may double their risk of developing a life-threatening complication, a new study suggests.

Researchers report connection between intestinal bacteria and development of diabetes

November 7, 2018
Researchers at Örebro University have, together with a well-known research team in Denmark, developed a method for studying how metabolism in gut bacteria influences health. Their method will now be published in its entirety ...

Genetic factors tied to obesity may protect against diabetes

November 2, 2018
Some genetic variations linked with obesity actually protect against Type 2 diabetes, heart attack and stroke, new findings suggest.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.